Ryan Zimmerman
Stock Analyst at BTIG
(4.05)
# 572
Out of 5,149 analysts
244
Total ratings
55.98%
Success rate
10.33%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Buy | $23 → $24 | $18.67 | +28.55% | 11 | Feb 27, 2026 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $9 → $8 | $2.87 | +178.75% | 11 | Feb 27, 2026 | |
| SOLV Solventum | Reiterates: Buy | $100 | $70.81 | +41.22% | 3 | Feb 27, 2026 | |
| ENOV Enovis | Maintains: Buy | $41 → $43 | $25.29 | +70.03% | 2 | Feb 26, 2026 | |
| ALC Alcon | Maintains: Buy | $91 → $92 | $83.08 | +10.74% | 14 | Feb 25, 2026 | |
| GKOS Glaukos | Reiterates: Buy | $131 | $117.75 | +11.25% | 17 | Feb 18, 2026 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $36 → $38 | $29.86 | +27.26% | 6 | Feb 18, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $97.97 | +14.32% | 11 | Feb 10, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.40 | +114.29% | 3 | Feb 10, 2026 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.07 | +460.75% | 7 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $91 | $78.13 | +16.47% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $412 | $384.59 | +7.13% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $616 | $497.42 | +23.84% | 23 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $340.16 | +2.60% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $13.21 | +81.68% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $1.92 | - | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.81 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.59 | +154.41% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.57 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.46 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $125.85 | +54.95% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.39 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $26.26 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $13.06 | +76.11% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $113.61 | +30.27% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.62 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $91.70 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $10.56 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $18.92 | +180.13% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.03 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $175.36 | +14.05% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $241.84 | +44.72% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $96.71 | +32.35% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.05 | +24.48% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.20 | +144.19% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $7.61 | +589.88% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $29.83 | - | 3 | Apr 2, 2020 |
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $18.67
Upside: +28.55%
Organogenesis Holdings
Feb 27, 2026
Maintains: Buy
Price Target: $9 → $8
Current: $2.87
Upside: +178.75%
Solventum
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $70.81
Upside: +41.22%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $25.29
Upside: +70.03%
Alcon
Feb 25, 2026
Maintains: Buy
Price Target: $91 → $92
Current: $83.08
Upside: +10.74%
Glaukos
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $117.75
Upside: +11.25%
Tactile Systems Technology
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $29.86
Upside: +27.26%
Zimmer Biomet Holdings
Feb 10, 2026
Reiterates: Buy
Price Target: $112
Current: $97.97
Upside: +14.32%
Spectral AI
Feb 10, 2026
Reiterates: Buy
Price Target: $3
Current: $1.40
Upside: +114.29%
Humacyte
Feb 9, 2026
Reiterates: Buy
Price Target: $6
Current: $1.07
Upside: +460.75%
Feb 9, 2026
Reiterates: Buy
Price Target: $91
Current: $78.13
Upside: +16.47%
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $384.59
Upside: +7.13%
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $497.42
Upside: +23.84%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $340.16
Upside: +2.60%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $13.21
Upside: +81.68%
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $1.92
Upside: -
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.81
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.59
Upside: +154.41%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.57
Upside: -
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.46
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $125.85
Upside: +54.95%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $34.39
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $26.26
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $13.06
Upside: +76.11%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $113.61
Upside: +30.27%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.62
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $91.70
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $10.56
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $18.92
Upside: +180.13%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.03
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $175.36
Upside: +14.05%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $241.84
Upside: +44.72%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $96.71
Upside: +32.35%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.05
Upside: +24.48%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.20
Upside: +144.19%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $7.61
Upside: +589.88%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $29.83
Upside: -